The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3-(tert-Butyl)-1-(3-nitrophenyl)-1H-pyrazol-5-yl)-3-(4-(8-(cyclopropylamino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl)-3-methylphenyl)urea ID: ALA4456854
PubChem CID: 142727702
Max Phase: Preclinical
Molecular Formula: C29H30N10O3
Molecular Weight: 566.63
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc([N+](=O)[O-])c2)ccc1-c1cnc(NC2CC2)c2ncnn12
Standard InChI: InChI=1S/C29H30N10O3/c1-17-12-19(10-11-22(17)23-15-30-26(33-18-8-9-18)27-31-16-32-38(23)27)34-28(40)35-25-14-24(29(2,3)4)36-37(25)20-6-5-7-21(13-20)39(41)42/h5-7,10-16,18H,8-9H2,1-4H3,(H,30,33)(H2,34,35,40)
Standard InChI Key: WTANOUKNZXAERM-UHFFFAOYSA-N
Molfile:
RDKit 2D
42 47 0 0 0 0 0 0 0 0999 V2000
17.3179 -12.2620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0231 -12.6665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7325 -12.2620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7325 -11.4407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3156 -11.4368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0231 -11.0238 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.8530 -10.2204 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0360 -10.1352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7040 -10.8860 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4419 -11.0321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1528 -11.4486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8654 -11.0386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8682 -10.2164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1526 -9.8059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4430 -10.2141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6072 -12.6726 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6095 -13.4939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5807 -9.8090 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2919 -10.2187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0044 -9.8112 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2906 -11.0400 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.7114 -10.2210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8018 -11.0371 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.6050 -11.2083 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.0147 -10.4971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4647 -9.8890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3849 -11.7461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5629 -11.7383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1502 -12.4464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5543 -13.1614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3795 -13.1639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7926 -12.4551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2015 -14.2065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0229 -14.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7312 -9.8054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8323 -10.4955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2464 -11.2066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2437 -9.7871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6536 -10.4955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3255 -12.4435 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.9081 -13.1527 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.9175 -11.7290 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 2 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
4 10 1 0
1 16 1 0
16 17 1 0
13 18 1 0
18 19 1 0
19 20 1 0
19 21 2 0
20 22 1 0
22 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 22 2 0
23 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
33 17 1 0
34 33 1 0
17 34 1 0
15 35 1 0
25 36 1 0
36 37 1 0
36 38 1 0
36 39 1 0
40 41 2 0
40 42 1 0
29 40 1 0
M CHG 2 40 1 42 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 566.63Molecular Weight (Monoisotopic): 566.2502AlogP: 5.71#Rotatable Bonds: 7Polar Surface Area: 157.20Molecular Species: NEUTRALHBA: 10HBD: 3#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 3#RO5 Violations (Lipinski): 3CX Acidic pKa: 11.30CX Basic pKa: 1.89CX LogP: 5.75CX LogD: 5.75Aromatic Rings: 5Heavy Atoms: 42QED Weighted: 0.17Np Likeness Score: -2.12
References 1. Kang SJ, Lee JW, Chung SH, Jang SY, Choi J, Suh KH, Kim YH, Ham YJ, Min KH.. (2019) Synthesis and anti-tumor activity of imidazopyrazines as TAK1 inhibitors., 163 [PMID:30576901 ] [10.1016/j.ejmech.2018.12.025 ]